Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Cabaletta Bio, Inc. | caba-ex321_6.htm |
EX-31.2 - EX-31.2 - Cabaletta Bio, Inc. | caba-ex312_8.htm |
EX-31.1 - EX-31.1 - Cabaletta Bio, Inc. | caba-ex311_9.htm |
EX-23.1 - EX-23.1 - Cabaletta Bio, Inc. | caba-ex231_171.htm |
EX-21.1 - EX-21.1 - Cabaletta Bio, Inc. | caba-ex211_172.htm |
EX-10.22 - EX-10.22 - Cabaletta Bio, Inc. | caba-ex1022_208.htm |
EX-4.3 - EX-4.3 - Cabaletta Bio, Inc. | caba-ex43_244.htm |
10-K - 10-K - Cabaletta Bio, Inc. | caba-10k_20191231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Cabaletta Bio, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: March 30, 2020 |
|
By: |
/s/ Anup Marda |
|
|
|
Anup Marda |
|
|
|
Chief Financial Officer (Principal Accounting and Financial Officer) |